▶ 調査レポート

抗生物質耐性バイオマーカーの世界市場 2020年:企業別、地域別、種類・用途別

• 英文タイトル:Global Antibiotic Resistance Biomarkers Market 2020 by Company, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。抗生物質耐性バイオマーカーの世界市場 2020年:企業別、地域別、種類・用途別 / Global Antibiotic Resistance Biomarkers Market 2020 by Company, Regions, Type and Application, Forecast to 2025 / D0804-14737資料のイメージです。• レポートコード:D0804-14737
• 出版社/出版日:GlobalInfoResearch / 2020年7月21日
※2025年版があります。お問い合わせください。

• レポート形態:英語、PDF、104ページ
• 納品方法:Eメール
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥487,200 (USD3,480)▷ お問い合わせ
  Multi User¥730,800 (USD5,220)▷ お問い合わせ
  Corporate User¥974,400 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、抗生物質耐性バイオマーカーの世界市場を広く調査・分析し、今後の市場展望をまとめております。抗生物質耐性バイオマーカーの種類別市場規模(血液バイオマーカー、尿バイオマーカー)、用途別市場規模(診断、創薬、オーダメイド医療、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。
・市場概要
・企業情報(販売量、市場シェア、製品概要、SWOT分析):Thermo Fisher Scientific、Creative Diagnostic、Bio-Rad Laboratories、Qiagen、Merck、Abbott、HiMedia Laboratories、GenMark Diagnostic、Cube Dx GmbH、Roche、Danaher Corporatory
・地域別グローバル市場分析 2015年-2020年
・抗生物質耐性バイオマーカーの北米市場(アメリカ、カナダ、メキシコ)
・抗生物質耐性バイオマーカーのヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・抗生物質耐性バイオマーカーのアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・抗生物質耐性バイオマーカーの南米市場(ブラジル、アルゼンチン)
・抗生物質耐性バイオマーカーの中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:血液バイオマーカー、尿バイオマーカー
・用途別分析:診断、創薬、オーダメイド医療、その他
・地域別市場規模予測 2021年-2025年
・調査の結果・結論

Market Overview
The global Antibiotic Resistance Biomarkers market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Antibiotic Resistance Biomarkers market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Antibiotic Resistance Biomarkers market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Antibiotic Resistance Biomarkers market has been segmented into:
Blood Biomarkers
Urine Biomarkers

By Application, Antibiotic Resistance Biomarkers has been segmented into:
Diagnostics
Drug Discovery
Personalized Medicine
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Antibiotic Resistance Biomarkers market presented in the report. This section sheds light on the sales growth of different regional and country-level Antibiotic Resistance Biomarkers markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Antibiotic Resistance Biomarkers market.

The report offers in-depth assessment of the growth and other aspects of the Antibiotic Resistance Biomarkers market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Antibiotic Resistance Biomarkers Market Share Analysis
Antibiotic Resistance Biomarkers competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Antibiotic Resistance Biomarkers sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Antibiotic Resistance Biomarkers sales, revenue and market share for each player covered in this report.

The major players covered in Antibiotic Resistance Biomarkers are:
Thermo Fisher Scientific
Creative Diagnostic
Bio-Rad Laboratories
Qiagen
Merck
Abbott
HiMedia Laboratories
GenMark Diagnostic
Cube Dx GmbH
Roche
Danaher Corporatory

レポート目次

1 Antibiotic Resistance Biomarkers Market Overview
1.1 Product Overview and Scope of Antibiotic Resistance Biomarkers
1.2 Classification of Antibiotic Resistance Biomarkers by Type
1.2.1 Global Antibiotic Resistance Biomarkers Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Antibiotic Resistance Biomarkers Revenue Market Share by Type in 2019
1.2.3 Blood Biomarkers
1.2.4 Urine Biomarkers
1.3 Global Antibiotic Resistance Biomarkers Market by Application
1.3.1 Overview: Global Antibiotic Resistance Biomarkers Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Diagnostics
1.3.3 Drug Discovery
1.3.4 Personalized Medicine
1.3.5 Others
1.4 Global Antibiotic Resistance Biomarkers Market by Regions
1.4.1 Global Antibiotic Resistance Biomarkers Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Antibiotic Resistance Biomarkers (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Antibiotic Resistance Biomarkers Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Antibiotic Resistance Biomarkers Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Antibiotic Resistance Biomarkers Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Antibiotic Resistance Biomarkers Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Antibiotic Resistance Biomarkers Status and Prospect (2015-2025)
2 Company Profiles
2.1 Thermo Fisher Scientific
2.1.1 Thermo Fisher Scientific Details
2.1.2 Thermo Fisher Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Thermo Fisher Scientific SWOT Analysis
2.1.4 Thermo Fisher Scientific Product and Services
2.1.5 Thermo Fisher Scientific Antibiotic Resistance Biomarkers Revenue, Gross Margin and Market Share (2018-2019)
2.2 Creative Diagnostic
2.2.1 Creative Diagnostic Details
2.2.2 Creative Diagnostic Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Creative Diagnostic SWOT Analysis
2.2.4 Creative Diagnostic Product and Services
2.2.5 Creative Diagnostic Antibiotic Resistance Biomarkers Revenue, Gross Margin and Market Share (2018-2019)
2.3 Bio-Rad Laboratories
2.3.1 Bio-Rad Laboratories Details
2.3.2 Bio-Rad Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Bio-Rad Laboratories SWOT Analysis
2.3.4 Bio-Rad Laboratories Product and Services
2.3.5 Bio-Rad Laboratories Antibiotic Resistance Biomarkers Revenue, Gross Margin and Market Share (2018-2019)
2.4 Qiagen
2.4.1 Qiagen Details
2.4.2 Qiagen Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Qiagen SWOT Analysis
2.4.4 Qiagen Product and Services
2.4.5 Qiagen Antibiotic Resistance Biomarkers Revenue, Gross Margin and Market Share (2018-2019)
2.5 Merck
2.5.1 Merck Details
2.5.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Merck SWOT Analysis
2.5.4 Merck Product and Services
2.5.5 Merck Antibiotic Resistance Biomarkers Revenue, Gross Margin and Market Share (2018-2019)
2.6 Abbott
2.6.1 Abbott Details
2.6.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Abbott SWOT Analysis
2.6.4 Abbott Product and Services
2.6.5 Abbott Antibiotic Resistance Biomarkers Revenue, Gross Margin and Market Share (2018-2019)
2.7 HiMedia Laboratories
2.7.1 HiMedia Laboratories Details
2.7.2 HiMedia Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 HiMedia Laboratories SWOT Analysis
2.7.4 HiMedia Laboratories Product and Services
2.7.5 HiMedia Laboratories Antibiotic Resistance Biomarkers Revenue, Gross Margin and Market Share (2018-2019)
2.8 GenMark Diagnostic
2.8.1 GenMark Diagnostic Details
2.8.2 GenMark Diagnostic Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 GenMark Diagnostic SWOT Analysis
2.8.4 GenMark Diagnostic Product and Services
2.8.5 GenMark Diagnostic Antibiotic Resistance Biomarkers Revenue, Gross Margin and Market Share (2018-2019)
2.9 Cube Dx GmbH
2.9.1 Cube Dx GmbH Details
2.9.2 Cube Dx GmbH Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Cube Dx GmbH SWOT Analysis
2.9.4 Cube Dx GmbH Product and Services
2.9.5 Cube Dx GmbH Antibiotic Resistance Biomarkers Revenue, Gross Margin and Market Share (2018-2019)
2.10 Roche
2.10.1 Roche Details
2.10.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Roche SWOT Analysis
2.10.4 Roche Product and Services
2.10.5 Roche Antibiotic Resistance Biomarkers Revenue, Gross Margin and Market Share (2018-2019)
2.11 Danaher Corporatory
2.11.1 Danaher Corporatory Details
2.11.2 Danaher Corporatory Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Danaher Corporatory SWOT Analysis
2.11.4 Danaher Corporatory Product and Services
2.11.5 Danaher Corporatory Antibiotic Resistance Biomarkers Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Antibiotic Resistance Biomarkers Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Antibiotic Resistance Biomarkers Players Market Share
3.2.2 Top 10 Antibiotic Resistance Biomarkers Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Antibiotic Resistance Biomarkers Revenue and Market Share by Regions
4.2 North America Antibiotic Resistance Biomarkers Revenue and Growth Rate (2015-2020)
4.3 Europe Antibiotic Resistance Biomarkers Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Antibiotic Resistance Biomarkers Revenue and Growth Rate (2015-2020)
4.5 South America Antibiotic Resistance Biomarkers Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Antibiotic Resistance Biomarkers Revenue and Growth Rate (2015-2020)
5 North America Antibiotic Resistance Biomarkers Revenue by Countries
5.1 North America Antibiotic Resistance Biomarkers Revenue by Countries (2015-2020)
5.2 USA Antibiotic Resistance Biomarkers Revenue and Growth Rate (2015-2020)
5.3 Canada Antibiotic Resistance Biomarkers Revenue and Growth Rate (2015-2020)
5.4 Mexico Antibiotic Resistance Biomarkers Revenue and Growth Rate (2015-2020)
6 Europe Antibiotic Resistance Biomarkers Revenue by Countries
6.1 Europe Antibiotic Resistance Biomarkers Revenue by Countries (2015-2020)
6.2 Germany Antibiotic Resistance Biomarkers Revenue and Growth Rate (2015-2020)
6.3 UK Antibiotic Resistance Biomarkers Revenue and Growth Rate (2015-2020)
6.4 France Antibiotic Resistance Biomarkers Revenue and Growth Rate (2015-2020)
6.5 Russia Antibiotic Resistance Biomarkers Revenue and Growth Rate (2015-2020)
6.6 Italy Antibiotic Resistance Biomarkers Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Antibiotic Resistance Biomarkers Revenue by Countries
7.1 Asia-Pacific Antibiotic Resistance Biomarkers Revenue by Countries (2015-2020)
7.2 China Antibiotic Resistance Biomarkers Revenue and Growth Rate (2015-2020)
7.3 Japan Antibiotic Resistance Biomarkers Revenue and Growth Rate (2015-2020)
7.4 Korea Antibiotic Resistance Biomarkers Revenue and Growth Rate (2015-2020)
7.5 India Antibiotic Resistance Biomarkers Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Antibiotic Resistance Biomarkers Revenue and Growth Rate (2015-2020)
8 South America Antibiotic Resistance Biomarkers Revenue by Countries
8.1 South America Antibiotic Resistance Biomarkers Revenue by Countries (2015-2020)
8.2 Brazil Antibiotic Resistance Biomarkers Revenue and Growth Rate (2015-2020)
8.3 Argentina Antibiotic Resistance Biomarkers Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Antibiotic Resistance Biomarkers by Countries
9.1 Middle East & Africa Antibiotic Resistance Biomarkers Revenue by Countries (2015-2020)
9.2 Saudi Arabia Antibiotic Resistance Biomarkers Revenue and Growth Rate (2015-2020)
9.3 UAE Antibiotic Resistance Biomarkers Revenue and Growth Rate (2015-2020)
9.4 Egypt Antibiotic Resistance Biomarkers Revenue and Growth Rate (2015-2020)
9.5 South Africa Antibiotic Resistance Biomarkers Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Antibiotic Resistance Biomarkers Revenue and Market Share by Type (2015-2020)
10.2 Global Antibiotic Resistance Biomarkers Market Forecast by Type (2019-2024)
10.3 Blood Biomarkers Revenue Growth Rate (2015-2025)
10.4 Urine Biomarkers Revenue Growth Rate (2015-2025)
11 Global Antibiotic Resistance Biomarkers Market Segment by Application
11.1 Global Antibiotic Resistance Biomarkers Revenue Market Share by Application (2015-2020)
11.2 Antibiotic Resistance Biomarkers Market Forecast by Application (2019-2024)
11.3 Diagnostics Revenue Growth (2015-2020)
11.4 Drug Discovery Revenue Growth (2015-2020)
11.5 Personalized Medicine Revenue Growth (2015-2020)
11.6 Others Revenue Growth (2015-2020)
12 Global Antibiotic Resistance Biomarkers Market Size Forecast (2021-2025)
12.1 Global Antibiotic Resistance Biomarkers Market Size Forecast (2021-2025)
12.2 Global Antibiotic Resistance Biomarkers Market Forecast by Regions (2021-2025)
12.3 North America Antibiotic Resistance Biomarkers Revenue Market Forecast (2021-2025)
12.4 Europe Antibiotic Resistance Biomarkers Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Antibiotic Resistance Biomarkers Revenue Market Forecast (2021-2025)
12.6 South America Antibiotic Resistance Biomarkers Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Antibiotic Resistance Biomarkers Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables
Table 1. Global Antibiotic Resistance Biomarkers Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Antibiotic Resistance Biomarkers by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Antibiotic Resistance Biomarkers Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Antibiotic Resistance Biomarkers Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Thermo Fisher Scientific Corporate Information, Location and Competitors
Table 6. Thermo Fisher Scientific Antibiotic Resistance Biomarkers Major Business
Table 7. Thermo Fisher Scientific Antibiotic Resistance Biomarkers Total Revenue (USD Million) (2017-2018)
Table 8. Thermo Fisher Scientific SWOT Analysis
Table 9. Thermo Fisher Scientific Antibiotic Resistance Biomarkers Product and Solutions
Table 10. Thermo Fisher Scientific Antibiotic Resistance Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Creative Diagnostic Corporate Information, Location and Competitors
Table 12. Creative Diagnostic Antibiotic Resistance Biomarkers Major Business
Table 13. Creative Diagnostic Antibiotic Resistance Biomarkers Total Revenue (USD Million) (2018-2019)
Table 14. Creative Diagnostic SWOT Analysis
Table 15. Creative Diagnostic Antibiotic Resistance Biomarkers Product and Solutions
Table 16. Creative Diagnostic Antibiotic Resistance Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Bio-Rad Laboratories Corporate Information, Location and Competitors
Table 18. Bio-Rad Laboratories Antibiotic Resistance Biomarkers Major Business
Table 19. Bio-Rad Laboratories Antibiotic Resistance Biomarkers Total Revenue (USD Million) (2017-2018)
Table 20. Bio-Rad Laboratories SWOT Analysis
Table 21. Bio-Rad Laboratories Antibiotic Resistance Biomarkers Product and Solutions
Table 22. Bio-Rad Laboratories Antibiotic Resistance Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Qiagen Corporate Information, Location and Competitors
Table 24. Qiagen Antibiotic Resistance Biomarkers Major Business
Table 25. Qiagen Antibiotic Resistance Biomarkers Total Revenue (USD Million) (2017-2018)
Table 26. Qiagen SWOT Analysis
Table 27. Qiagen Antibiotic Resistance Biomarkers Product and Solutions
Table 28. Qiagen Antibiotic Resistance Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Merck Corporate Information, Location and Competitors
Table 30. Merck Antibiotic Resistance Biomarkers Major Business
Table 31. Merck Antibiotic Resistance Biomarkers Total Revenue (USD Million) (2017-2018)
Table 32. Merck SWOT Analysis
Table 33. Merck Antibiotic Resistance Biomarkers Product and Solutions
Table 34. Merck Antibiotic Resistance Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Abbott Corporate Information, Location and Competitors
Table 36. Abbott Antibiotic Resistance Biomarkers Major Business
Table 37. Abbott Antibiotic Resistance Biomarkers Total Revenue (USD Million) (2017-2018)
Table 38. Abbott SWOT Analysis
Table 39. Abbott Antibiotic Resistance Biomarkers Product and Solutions
Table 40. Abbott Antibiotic Resistance Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. HiMedia Laboratories Corporate Information, Location and Competitors
Table 42. HiMedia Laboratories Antibiotic Resistance Biomarkers Major Business
Table 43. HiMedia Laboratories Antibiotic Resistance Biomarkers Total Revenue (USD Million) (2017-2018)
Table 44. HiMedia Laboratories SWOT Analysis
Table 45. HiMedia Laboratories Antibiotic Resistance Biomarkers Product and Solutions
Table 46. HiMedia Laboratories Antibiotic Resistance Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. GenMark Diagnostic Corporate Information, Location and Competitors
Table 48. GenMark Diagnostic Antibiotic Resistance Biomarkers Major Business
Table 49. GenMark Diagnostic Antibiotic Resistance Biomarkers Total Revenue (USD Million) (2017-2018)
Table 50. GenMark Diagnostic SWOT Analysis
Table 51. GenMark Diagnostic Antibiotic Resistance Biomarkers Product and Solutions
Table 52. GenMark Diagnostic Antibiotic Resistance Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Cube Dx GmbH Corporate Information, Location and Competitors
Table 54. Cube Dx GmbH Antibiotic Resistance Biomarkers Major Business
Table 55. Cube Dx GmbH Antibiotic Resistance Biomarkers Total Revenue (USD Million) (2017-2018)
Table 56. Cube Dx GmbH SWOT Analysis
Table 57. Cube Dx GmbH Antibiotic Resistance Biomarkers Product and Solutions
Table 58. Cube Dx GmbH Antibiotic Resistance Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Roche Corporate Information, Location and Competitors
Table 60. Roche Antibiotic Resistance Biomarkers Major Business
Table 61. Roche Antibiotic Resistance Biomarkers Total Revenue (USD Million) (2017-2018)
Table 62. Roche SWOT Analysis
Table 63. Roche Antibiotic Resistance Biomarkers Product and Solutions
Table 64. Roche Antibiotic Resistance Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Danaher Corporatory Corporate Information, Location and Competitors
Table 66. Danaher Corporatory Antibiotic Resistance Biomarkers Major Business
Table 67. Danaher Corporatory Antibiotic Resistance Biomarkers Total Revenue (USD Million) (2017-2018)
Table 68. Danaher Corporatory SWOT Analysis
Table 69. Danaher Corporatory Antibiotic Resistance Biomarkers Product and Solutions
Table 70. Danaher Corporatory Antibiotic Resistance Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Global Antibiotic Resistance Biomarkers Revenue (Million USD) by Players (2015-2020)
Table 72. Global Antibiotic Resistance Biomarkers Revenue Share by Players (2015-2020)
Table 73. Global Antibiotic Resistance Biomarkers Revenue (Million USD) by Regions (2015-2020)
Table 74. Global Antibiotic Resistance Biomarkers Revenue Market Share by Regions (2015-2020)
Table 75. North America Antibiotic Resistance Biomarkers Revenue by Countries (2015-2020)
Table 76. North America Antibiotic Resistance Biomarkers Revenue Market Share by Countries (2015-2020)
Table 77. Europe Antibiotic Resistance Biomarkers Revenue (Million USD) by Countries (2015-2020)
Table 78. Asia-Pacific Antibiotic Resistance Biomarkers Revenue (Million USD) by Countries (2015-2020)
Table 79. South America Antibiotic Resistance Biomarkers Revenue by Countries (2015-2020)
Table 80. South America Antibiotic Resistance Biomarkers Revenue Market Share by Countries (2015-2020)
Table 81. Middle East and Africa Antibiotic Resistance Biomarkers Revenue (Million USD) by Countries (2015-2020)
Table 82. Middle East and Africa Antibiotic Resistance Biomarkers Revenue Market Share by Countries (2015-2020)
Table 83. Global Antibiotic Resistance Biomarkers Revenue (Million USD) by Type (2015-2020)
Table 84. Global Antibiotic Resistance Biomarkers Revenue Share by Type (2015-2020)
Table 85. Global Antibiotic Resistance Biomarkers Revenue Forecast by Type (2021-2025)
Table 86. Global Antibiotic Resistance Biomarkers Revenue by Application (2015-2020)
Table 87. Global Antibiotic Resistance Biomarkers Revenue Share by Application (2015-2020)
Table 88. Global Antibiotic Resistance Biomarkers Revenue Forecast by Application (2021-2025)
Table 89. Global Antibiotic Resistance Biomarkers Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Antibiotic Resistance Biomarkers Picture
Figure 2. Global Antibiotic Resistance Biomarkers Revenue Market Share by Type in 2019
Figure 3. Blood Biomarkers Picture
Figure 4. Urine Biomarkers Picture
Figure 5. Antibiotic Resistance Biomarkers Revenue Market Share by Application in 2019
Figure 6. Diagnostics Picture
Figure 7. Drug Discovery Picture
Figure 8. Personalized Medicine Picture
Figure 9. Others Picture
Figure 10. Global Antibiotic Resistance Biomarkers Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Antibiotic Resistance Biomarkers Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Antibiotic Resistance Biomarkers Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Antibiotic Resistance Biomarkers Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Antibiotic Resistance Biomarkers Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Antibiotic Resistance Biomarkers Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Antibiotic Resistance Biomarkers Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Antibiotic Resistance Biomarkers Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Antibiotic Resistance Biomarkers Revenue Market Share in 2019
Figure 19. Global Top 10 Players Antibiotic Resistance Biomarkers Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Antibiotic Resistance Biomarkers Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Antibiotic Resistance Biomarkers Revenue Market Share by Regions (2015-2020)
Figure 23. Global Antibiotic Resistance Biomarkers Revenue Market Share by Regions in 2018
Figure 24. North America Antibiotic Resistance Biomarkers Revenue and Growth Rate (2015-2020)
Figure 25. Europe Antibiotic Resistance Biomarkers Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Antibiotic Resistance Biomarkers Revenue and Growth Rate (2015-2020)
Figure 27. South America Antibiotic Resistance Biomarkers Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Antibiotic Resistance Biomarkers Revenue and Growth Rate (2015-2020)
Figure 29. North America Antibiotic Resistance Biomarkers Revenue Market Share by Countries (2015-2020)
Figure 30. North America Antibiotic Resistance Biomarkers Revenue Market Share by Countries in 2019
Figure 31. USA Antibiotic Resistance Biomarkers Revenue and Growth Rate (2015-2020)
Figure 32. Canada Antibiotic Resistance Biomarkers Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Antibiotic Resistance Biomarkers Revenue and Growth Rate (2015-2020)
Figure 34. Europe Antibiotic Resistance Biomarkers Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Antibiotic Resistance Biomarkers Revenue Market Share by Countries in 2019
Figure 36. Germany Antibiotic Resistance Biomarkers Revenue and Growth Rate (2015-2020)
Figure 37. UK Antibiotic Resistance Biomarkers Revenue and Growth Rate (2015-2020)
Figure 38. France Antibiotic Resistance Biomarkers Revenue and Growth Rate (2015-2020)
Figure 39. Russia Antibiotic Resistance Biomarkers Revenue and Growth Rate (2015-2020)
Figure 40. Italy Antibiotic Resistance Biomarkers Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Antibiotic Resistance Biomarkers Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Antibiotic Resistance Biomarkers Revenue Market Share by Countries in 2019
Figure 43. China Antibiotic Resistance Biomarkers Revenue and Growth Rate (2015-2020)
Figure 44. Japan Antibiotic Resistance Biomarkers Revenue and Growth Rate (2015-2020)
Figure 45. Korea Antibiotic Resistance Biomarkers Revenue and Growth Rate (2015-2020)
Figure 46. India Antibiotic Resistance Biomarkers Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Antibiotic Resistance Biomarkers Revenue and Growth Rate (2015-2020)
Figure 48. South America Antibiotic Resistance Biomarkers Revenue Market Share by Countries (2015-2020)
Figure 49. South America Antibiotic Resistance Biomarkers Revenue Market Share by Countries in 2019
Figure 50. Brazil Antibiotic Resistance Biomarkers Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Antibiotic Resistance Biomarkers Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Antibiotic Resistance Biomarkers Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Antibiotic Resistance Biomarkers Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Antibiotic Resistance Biomarkers Revenue and Growth Rate (2015-2020)
Figure 55. UAE Antibiotic Resistance Biomarkers Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Antibiotic Resistance Biomarkers Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Antibiotic Resistance Biomarkers Revenue and Growth Rate (2015-2020)
Figure 58. Global Antibiotic Resistance Biomarkers Revenue Share by Type (2015-2020)
Figure 59. Global Antibiotic Resistance Biomarkers Revenue Share by Type in 2019
Figure 60. Global Antibiotic Resistance Biomarkers Market Share Forecast by Type (2021-2025)
Figure 61. Global Blood Biomarkers Revenue Growth Rate (2015-2020)
Figure 62. Global Urine Biomarkers Revenue Growth Rate (2015-2020)
Figure 63. Global Antibiotic Resistance Biomarkers Revenue Share by Application (2015-2020)
Figure 64. Global Antibiotic Resistance Biomarkers Revenue Share by Application in 2019
Figure 65. Global Antibiotic Resistance Biomarkers Market Share Forecast by Application (2021-2025)
Figure 66. Global Diagnostics Revenue Growth Rate (2015-2020)
Figure 67. Global Drug Discovery Revenue Growth Rate (2015-2020)
Figure 68. Global Personalized Medicine Revenue Growth Rate (2015-2020)
Figure 69. Global Others Revenue Growth Rate (2015-2020)
Figure 70. Global Antibiotic Resistance Biomarkers Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Antibiotic Resistance Biomarkers Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Antibiotic Resistance Biomarkers Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Antibiotic Resistance Biomarkers Revenue Market Forecast (2021-2025)
Figure 74. Europe Antibiotic Resistance Biomarkers Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Antibiotic Resistance Biomarkers Revenue Market Forecast (2021-2025)
Figure 76. South America Antibiotic Resistance Biomarkers Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Antibiotic Resistance Biomarkers Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel